Cargando…

Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?

OBJECTIVE: Ex vivo radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. MATERIALS AND METHODS: We prospectively evaluated the retrieved tissue specimens d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Navjot, Kumar, Rajender, Rana, Nivedita, Krishnaraju, Venkata Subramanian, Mittal, Bhagwant Rai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380811/
https://www.ncbi.nlm.nih.gov/pubmed/35982818
http://dx.doi.org/10.4103/ijnm.ijnm_172_21
_version_ 1784768948594540544
author Kaur, Navjot
Kumar, Rajender
Rana, Nivedita
Krishnaraju, Venkata Subramanian
Mittal, Bhagwant Rai
author_facet Kaur, Navjot
Kumar, Rajender
Rana, Nivedita
Krishnaraju, Venkata Subramanian
Mittal, Bhagwant Rai
author_sort Kaur, Navjot
collection PubMed
description OBJECTIVE: Ex vivo radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. MATERIALS AND METHODS: We prospectively evaluated the retrieved tissue specimens during PET/CT-guided biopsies for the presence of radioactivity. The qualitative radioactivity was measured by acquiring PET/CT images of the specimen. For quantitative analysis, a multichannel-analyzer (MCA) was used, and a counting-factor (CF) in counts/mCi.mm(3) was calculated based on background-corrected net-counts, tissue-volume (mm(3)), and exponential tracer-activity during biopsy (mCi). The CF-values were compared with the 2-(fluorine-18) fluoro-2-deoxy-D-glucose-avidity in the target lesion and correlated with the histopathology. RESULTS: A total of 49 patients (30 males) aged 51.8 ± 17.8 years were recruited for the biopsy, and radioactivity was measured. All the specimens revealed the presence of radioactivity on PET/CT images of the specimens and MCA counting. The mean CF-values were 17.2 ± 15.6 counts/mCi.mm(3). One sample had meager counts with a CF-value of 0.162 and was subjected to re-biopsy after repositioning the coaxial needle to the hypermetabolic site. Pathological diagnosis was established in all the patients (malignancy-29, benign-20). The CF-values were significantly higher in malignant lesions than benign (21.45 ± 18.05 vs. 10.76 ± 8.96 counts/mCi.mm(3), P = 0.025). CF-values and maximum standardized uptake value had a significant correlation (Pearson's r = 0.457, P = 0.001). CONCLUSION: The ex vivo measurement of the radioactivity of retrieved tissue specimens during PET/CT-guided biopsy helps to confirm the sampling from viable region and a highly practical approach to avoid erroneous sampling of a lesion with a large necrotic area. It is also helpful in predicting the nature of the biopsied lesion before the histopathological analysis.
format Online
Article
Text
id pubmed-9380811
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93808112022-08-17 Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? Kaur, Navjot Kumar, Rajender Rana, Nivedita Krishnaraju, Venkata Subramanian Mittal, Bhagwant Rai Indian J Nucl Med Original Article OBJECTIVE: Ex vivo radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. MATERIALS AND METHODS: We prospectively evaluated the retrieved tissue specimens during PET/CT-guided biopsies for the presence of radioactivity. The qualitative radioactivity was measured by acquiring PET/CT images of the specimen. For quantitative analysis, a multichannel-analyzer (MCA) was used, and a counting-factor (CF) in counts/mCi.mm(3) was calculated based on background-corrected net-counts, tissue-volume (mm(3)), and exponential tracer-activity during biopsy (mCi). The CF-values were compared with the 2-(fluorine-18) fluoro-2-deoxy-D-glucose-avidity in the target lesion and correlated with the histopathology. RESULTS: A total of 49 patients (30 males) aged 51.8 ± 17.8 years were recruited for the biopsy, and radioactivity was measured. All the specimens revealed the presence of radioactivity on PET/CT images of the specimens and MCA counting. The mean CF-values were 17.2 ± 15.6 counts/mCi.mm(3). One sample had meager counts with a CF-value of 0.162 and was subjected to re-biopsy after repositioning the coaxial needle to the hypermetabolic site. Pathological diagnosis was established in all the patients (malignancy-29, benign-20). The CF-values were significantly higher in malignant lesions than benign (21.45 ± 18.05 vs. 10.76 ± 8.96 counts/mCi.mm(3), P = 0.025). CF-values and maximum standardized uptake value had a significant correlation (Pearson's r = 0.457, P = 0.001). CONCLUSION: The ex vivo measurement of the radioactivity of retrieved tissue specimens during PET/CT-guided biopsy helps to confirm the sampling from viable region and a highly practical approach to avoid erroneous sampling of a lesion with a large necrotic area. It is also helpful in predicting the nature of the biopsied lesion before the histopathological analysis. Wolters Kluwer - Medknow 2022 2022-07-08 /pmc/articles/PMC9380811/ /pubmed/35982818 http://dx.doi.org/10.4103/ijnm.ijnm_172_21 Text en Copyright: © 2022 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kaur, Navjot
Kumar, Rajender
Rana, Nivedita
Krishnaraju, Venkata Subramanian
Mittal, Bhagwant Rai
Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?
title Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?
title_full Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?
title_fullStr Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?
title_full_unstemmed Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?
title_short Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?
title_sort ex vivo measurement of the radioactivity of pet/ct-guided biopsy specimen: is it helpful to confirm the sampling from a viable region of the tumor and the nature of the lesion?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380811/
https://www.ncbi.nlm.nih.gov/pubmed/35982818
http://dx.doi.org/10.4103/ijnm.ijnm_172_21
work_keys_str_mv AT kaurnavjot exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion
AT kumarrajender exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion
AT rananivedita exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion
AT krishnarajuvenkatasubramanian exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion
AT mittalbhagwantrai exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion